C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/18/2004	WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004	WO2004078205A8 Targeting a protein prc1 for the treatment of pancreatic cancer
11/18/2004	WO2004078097A8 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
11/18/2004	WO2004075836A9 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
11/18/2004	WO2004074841A3 Kor3l-like-proteins and methods of modulating kor3l-mediated activity
11/18/2004	WO2004067695A8 Process and device for preparing phycoerythrin with high od ratio
11/18/2004	WO2004050858A3 Compositions, splice variants and methods relating to colon specific genes and proteins
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	WO2004046315A3 Compositions and methods utilizing human gamma-hydroxybutyrate receptor
11/18/2004	WO2004042358A3 HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
11/18/2004	WO2004041854A3 Essential novel bacterial polypeptides
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	WO2004035606A3 Bace binding peptides and uses thereof
11/18/2004	WO2004034093A3 Caterpiller gene family
11/18/2004	WO2004033710A3 Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
11/18/2004	WO2004027064A3 Ghrh analogues
11/18/2004	WO2004027042A3 Isolation and use of ryanodine receptors
11/18/2004	WO2004019893A3 Modulators of angiogenesis
11/18/2004	WO2004007673A3 Neuronal gene expression patterns
11/18/2004	WO2004004447A3 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
11/18/2004	WO2003102156A3 Heterologous stimulus-gated ion channels and methods of using same
11/18/2004	WO2003102149A3 Identification of a novel bhd gene
11/18/2004	WO2003096797A3 Method of increasing plant organ and seed size in a plant
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003084312A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato
11/18/2004	WO2003080805A3 Kinases and phosphatases
11/18/2004	WO2003076591A8 Compositions and methods for generating an immune response
11/18/2004	WO2003070893A3 Wip, a wasp-associated protein
11/18/2004	WO2003055982A3 Compositions and methods relating to endometrial specific genes and proteins
11/18/2004	WO2003054219A3 Nucleic acid-associated proteins
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	WO2001085943A9 Anergy associated genes
11/18/2004	US20040231013 Transgenic mouse expressing fluorescent protein for use of whole body imaging in comparative disease diagnosis and prognosis; colorimetric analysis
11/18/2004	US20040231011 Decoy receptor (DCR3) of tumor necrosis factor receptor for use as tool in enhancing cell sensitivity to antitumor agents
11/18/2004	US20040231010 Lysozyme transgenic ungulates
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230041 Extracting and isolating corn protein using diafiltration
11/18/2004	US20040230040 Modified growth hormone protein for use in prevention and treatment of cachexia associated with secondary effect of viral or metabolic diseases
11/18/2004	US20040230038 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040230034 Hybrid heterodimeric protein hormone and method of using same
11/18/2004	US20040230032 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229832 Vaccines containing ribavirin and methods of use thereof
11/18/2004	US20040229827 Dna immunization vectors
11/18/2004	US20040229811 Compounds and methods for modulating desmosomal cadherin-mediated functions
11/18/2004	US20040229809 Immunogenic peptides from the HPV E7 protein
11/18/2004	US20040229808 Cosmetic compositions containing short bioactive peptides
11/18/2004	US20040229806 Hirulog-like peptide and gene therapy
11/18/2004	US20040229804 Tribonectins
11/18/2004	US20040229802 Methods and compositions for treating ocular disease
11/18/2004	US20040229797 Protein that comprises an amino-acid in which one or several amino acids are deleted, substituted or added, and has effects of controlling cell migration and cell death in L-FILIP, S-FILIP, or other amino-acid sequence
11/18/2004	US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/18/2004	US20040229793 Compositions and methods for less immunogenic protein formulations
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229787 Transforming growth factor alpha Hlll
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/18/2004	US20040229779 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers.
11/18/2004	US20040229772 vaccines which are specific against the class of E. coli that gives rise to antibodies that cross-react with and cross-protect against the more common members of the CS4-CFA/I family
11/18/2004	US20040229367 Methods for monitoring multiple gene expression
11/18/2004	US20040229366 Combinations of genes for producing seed plants exhibiting modulated reproductive development
11/18/2004	US20040229365 Method to control gene expression in bacteria, namely Rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production
11/18/2004	US20040229361 Mammalian cell line for use as tool in preparation of gene transfer sequences; tissue engineering; bioreactor for production of therapeutic proteins
11/18/2004	US20040229360 Transgenic ventricle tissue for use as tools in screening modulators and treatments for cardiovascular disorders; tissue targeted therapy
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229334 Process for manufacture of nematode-extracted anticoagulant protein (NAP)
11/18/2004	US20040229333 Electroprocessed fibrin-based matrices and tissues
11/18/2004	US20040229320 Method for procucing L-amino acid using bacterium, belonging to the genus Escherichia, lacking active mlc gene
11/18/2004	US20040229318 Erythropoietin conjugate compounds with extended half-lives
11/18/2004	US20040229317 Nucleotide sequences coding amino acid transport protein for use in identifying modulator for treatment of cell proliferative and tissue distribution disorders
11/18/2004	US20040229316 Comprises membrane proteins for use in identifying modultaors for treatment, prevention and diagnosis of inflammatory, central nervous system or gastrointestinal disorders; drug screening
11/18/2004	US20040229315 nucleotide sequences that code human transient receptor potential channel polypeptides or fragments; genetic vectors, host cells, antibodies, and recombinant and synthetic methods for producing polypeptides; drug screening; medical diagnosis
11/18/2004	US20040229312 Serine protease ligand comprising protease inhibitor domain for use in treatment of inflammation, infection, cell proliferative, skin, liver and respiratory disorders
11/18/2004	US20040229308 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
11/18/2004	US20040229307 Guanylate-binding protein
11/18/2004	US20040229305 Novel polynucleotides encoding useful polypeptides in corynebacterium glutamicum SSP. lactofermentum
11/18/2004	US20040229304 Transport proteins; for drug screening/diagnosis/therapy; genetic engineering; bacteriophages
11/18/2004	US20040229298 Methods and compositions for treating cervical cancer
11/18/2004	US20040229289 Antigen binding peptides (abtides) from peptide libraries
11/18/2004	US20040229288 Using inhibition of von willebrand factor and glycoprotein Ib binding to identify anticoagulant agents; using increased glycokallidin concentration to diagnose cardiovascular disorders
11/18/2004	US20040229287 Using gel immobilized fusion polypeptides to screen and monitor drug-polypeptide interactions; drug screening; identifying apoptosis modulators; antitumor agents
11/18/2004	US20040229286 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
11/18/2004	US20040229283 Using mass altering label to generate a protein signature for use as diagnostic indicator in detection of cell proliferative, autoimmune, respiratory and neurodegenerative diseases; high throughput analysis of proteomes
11/18/2004	US20040229281 Methods for differentiating and monitoring parathyroid and bone status related diseases
11/18/2004	US20040229280 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
11/18/2004	US20040229279 Diagnostic drugs for autoimmune diseases
11/18/2004	US20040229278 Protein from plasma membrane of adipocytes; controlling glucose uptake
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229275 Comprises nucleotide sequences coding membrane transport protein for use in identifying modulators for treatment of low high density lipoprotein concentration, high triglyceride levels and/or cardiovascular disorders
11/18/2004	US20040229274 Synaptic activation protein compositions and method
11/18/2004	US20040229273 Comprises nucleotide sequences coding flea molting regulatory protein for use in identifying modulators which prevent flea infestation; biological pest control; veterinary medicine
11/18/2004	US20040229267 Tumor suppressor pathway in C. elegans
11/18/2004	US20040229264 Bioassay which utilizes interleukin allelic sequences and variable numbers of tandem repeats to diagnose and prognose cardiovascular disorders
11/18/2004	US20040229262 Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v

1 ... 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 ... 2916